$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Department of Infectious Diseases
Department of Infectious Diseases
多替阿巴拉米片国内上市了吗?
2025-10-19 11:44:20
Check Details
绥美凯的用法及用量
2025-10-19 11:44:20
Check Details
绥美凯的适应症是什么?
2025-10-19 11:44:20
Check Details
多替阿巴拉米片的适应症是什么?
2025-10-19 11:44:20
Check Details
绥美凯什么时候上市的?
2025-10-19 11:44:20
Check Details
绥美凯疗效好吗?
2025-10-19 11:44:20
Check Details
绥美凯在中国上市了吗?
2025-10-19 11:44:20
Check Details
多替阿巴拉米片多少钱一盒?
2025-10-19 11:44:20
Check Details
多替阿巴拉米片的效果怎么样?
2025-10-19 11:44:20
Check Details
服用绥美凯能活多久?
2025-10-19 11:44:20
Check Details
绥美凯怎么买?
2025-10-19 11:44:20
Check Details
绥美凯的效果好吗?
2025-10-19 11:44:20
Check Details
1
2
...
5
6
7
8
9
10
11
...
319
320
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Bedaquiline for Drug-Resistant TB: 24-Week Regimen, Combination Duration, and When to Stop or Extend
2
Bedaquiline Drug Interactions: CYP3A4 and QT Prolongation Risks
3
Epclusa (Sofosbuvir/Velpatasvir) Pan-Genotypic HCV Treatment: Mechanism, Efficacy, and Dosing
4
Laos Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) Generic Guide: Efficacy, Regimen Selection, and Precautions
5
Letermovir: Proper Usage and Important Precautions
6
Pretomanid Combination Therapy Safety Guide: BPaL Regimen Adverse Reaction Recognition and Monitoring
7
Valganciclovir (Valcyte) in Post-Transplant CMV Management: A Comprehensive Guide
8
Pretomanid Medication Guide: Core Agent in the BPaL Regimen for Drug-Resistant Tuberculosis
9
Linezolid for MRSA Pneumonia: Efficacy Evidence, Clinical Advantages, and Rational Use
10
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
11
Cabotegravir Sodium: Pioneering Long-Acting Solution for HIV Treatment and Prevention
12
Biktarvy (Bictegravir/Emtricitabine/TAF) Dosing & Food Administration Guide